Criterium Inc. is a leader in global contract research for the pharmaceutical, biotech, and medical device industries. Established in 1991 and headquartered in the United States, the company has been providing innovative research solutions for over 30 years. Criterium's success in clinical trials is attributed to the dedication of its executive management and project teams, who focus on delivering exceptional personal attention and services. Their approach connects, controls, and communicates all elements involved in clinical trials and drug development, ensuring efficiency and effectiveness.
The company's clinical trial monitoring team brings strong expertise in healthcare, clinical research management, regulatory affairs, and quality assurance, adhering to ICH-GCP standards. Their comprehensive approach covers project management and monitoring functions, ensuring adherence to the highest industry standards and regulations.
Criterium Inc. operates primarily in the biotechnology and pharmaceutical sectors, catering to the specific research and development needs of these industries. While the specifics of their funding history are not available, the company has established a reputable presence in the industry, offering reliable and innovative solutions for its clientele. Their track record of success and longevity in the market positions them as a noteworthy player in the contract research space.
There is no investment information
No recent news or press coverage available for Criterium Inc..